Drug 1
Generic/Working Name	PHY906, KD018, YIV‐906
Trade Name	YIV‐906
Company Name	Yiviva Inc.
Dose	800 b.i.d. milligrams (mg) per day
Route	Oral (p.o.)
Schedule of Administration	Patients were initially treated for two 21‐day courses with PHY906 800 mg b.i.d. + capecitabine 750 mg/m2 b.i.d. according to the following schedule: capecitabine 14 days on treatment, days 1 through 14, and 7 days off treatment; PHY906 days 1 through 4 and days 8 through 11 of each course. Patients might remain on study beyond their initial two courses of treatment until tumor progression or unacceptable toxicity mandated their removal.
Drug 2
Generic/Working Name	Xeloda
Trade Name	Capecitabine
Company Name	Roche
Dose	750 milligrams (mg) per squared meter (m2)
Route	Oral (p.o.)
Schedule of Administration	Patients were initially be treated for two 21‐day courses with PHY906 800 mg b.i.d. + capecitabine 750 mg/m2 b.i.d. according to the following schedule: capecitabine 14 days on treatment and 7 days off treatment and PHY906 days 1 through 4 and days 8 through 11 of each course. Patients might remain on study beyond their initial two courses of treatment until tumor progression or unacceptable toxicity mandated their removal.